4.7 Article

The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer's Disease in APP/PS1 Mice

Related references

Note: Only part of the references are listed.
Editorial Material Clinical Neurology

Aducanumab and the FDA - where are we now?

Howard Fillit et al.

Summary: The amyloid antibody aducanumab is under FDA review, but did not receive recommendation for approval from the advisory committee, leading to questions about the sufficiency of existing evidence of efficacy.

NATURE REVIEWS NEUROLOGY (2021)

Article Neurosciences

Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment

Mingyan Guo et al.

Summary: This study revealed that patients newly diagnosed with AD or MCI have gut dysbiosis, characterized by a decrease in potentially protective microbiome and an increase in microbiome promoting inflammation. Furthermore, the degree of gut dysbiosis worsens as the disease progresses from MCI to AD.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Cell Biology

Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease

Zongxin Ling et al.

Summary: The study found that gut dysbiosis in Chinese Alzheimer's disease (AD) patients results in a decrease in bacterial diversity, a reduction in butyrate-producing genera positively correlated with cognitive scores, and an increase in lactate-producing genera inversely correlated with these indicators. This shift in gut dysbiosis contributes to immune disturbances in the host, serving as potential non-invasive biomarkers for distinguishing AD patients from controls. Additionally, altered functional modules in the gut microbiota of AD patients may produce immunomodulatory metabolites.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Geriatrics & Gerontology

TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study

Florinda Ferreri et al.

Summary: The study revealed reduced excitability in the sensorimotor cortex and disrupted EEG synchronization in aMCI patients, with alterations in intertrial coherence in different frequency bands serving as potential predictors of cognitive status in aMCI. Importantly, differences in beta and gamma coherence were observed between those who clinically converted to AD and those who remained cognitively stable, suggesting these changes may serve as neurophysiological biomarkers for AD.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Letter Clinical Neurology

Don't Hurt Me No More: State-dependent Transcranial Magnetic Stimulation for the treatment of specific phobia

Sara Borgomaneri et al.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Article Psychology, Clinical

Frozen in (e)motion: How reactive motor inhibition is influenced by the emotional content of stimuli in healthy and psychiatric populations

Simone Battaglia et al.

Summary: This article reviews the impact of emotional stimuli on inhibitory control, discussing both the interference and advantage of emotional stimuli on action inhibition performance, as well as exploring their effects on individuals with psychiatric disorders. Key factors such as relevance, intensity, and valence of emotional stimuli, as well as the component of motor control affected, are highlighted in understanding how emotion integrates into core executive functions.

BEHAVIOUR RESEARCH AND THERAPY (2021)

Article Biochemistry & Molecular Biology

The Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2

John Tsu-An Hsu et al.

Summary: Elderly individuals with dementia, particularly Alzheimer's disease, may be more susceptible to severe COVID-19 due to increased levels of beta-amyloid (Aβ). Aβ(1-42) specifically binds to viral proteins of SARS-CoV-2, such as the spike protein S1 subunit and ACE2 receptor, potentially enhancing viral entry into cells and increasing inflammation. Further research is needed to explore the mechanisms underlying this interaction and investigate the potential benefits of reducing Aβ(1-42) levels in combating COVID-19 and AD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Behavioral Sciences

Memories are not written in stone: Re-writing fear memories by means of non-invasive brain stimulation and optogenetic manipulations

Sara Borgomaneri et al.

Summary: The acquisition and extinction of fear associative memory rely on coordinated neural activity within specific brain regions, particularly the amygdala and prefrontal cortex. By comparing brain networks involved in fear processing in humans and other species, we can gain insights into fear mechanisms and potential treatments for fear-related disorders.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Article Clinical Neurology

Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019

David S. Knopman et al.

Summary: Aducanumab recently underwent two large phase III clinical trials that were stopped prematurely by the sponsor due to divergent outcomes. One trial showed potential benefits from high doses of Aducanumab, while the other did not show any benefits. Further analysis is needed to determine the true efficacy as a treatment for Alzheimer's disease.

ALZHEIMERS & DEMENTIA (2021)

Review Endocrinology & Metabolism

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

Ygor Parladore Silva et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Biochemistry & Molecular Biology

State-Dependent TMS over Prefrontal Cortex Disrupts Fear-Memory Reconsolidation and Prevents the Return of Fear

Sara Borgomaneri et al.

CURRENT BIOLOGY (2020)

Article Clinical Neurology

Symptomatic amyloid-related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab

Lawren VandeVrede et al.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)

Letter Clinical Neurology

Beta-tACS does not impact the dynamics of motor memory consolidation

Liliia Roshchupkina et al.

BRAIN STIMULATION (2020)

Review Gastroenterology & Hepatology

The role of short-chain fatty acids in microbiota-gut-brain communication

Boushra Dalile et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Clinical Neurology

Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota

Binyin Li et al.

ALZHEIMERS & DEMENTIA (2019)

Review Biochemistry & Molecular Biology

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Justin M. Long et al.

Review Cell Biology

Multitarget therapeutic strategies for Alzheimer's disease

Mostafa M. Ibrahim et al.

NEURAL REGENERATION RESEARCH (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Review Neurosciences

Non-invasive Brain Stimulation: A Paradigm Shift in Understanding Brain Oscillations

Johannes Vosskuhl et al.

FRONTIERS IN HUMAN NEUROSCIENCE (2018)

Article Multidisciplinary Sciences

Context-dependent extinction of threat memories: influences of healthy aging

Simone Battaglia et al.

SCIENTIFIC REPORTS (2018)

Review Clinical Neurology

Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward

David Hsu et al.

CURRENT ALZHEIMER RESEARCH (2017)

Review Medicine, Research & Experimental

Microglia in Alzheimer's disease

Heela Sarlus et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Multidisciplinary Sciences

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

Mariana X. Byndloss et al.

SCIENCE (2017)

Article Multidisciplinary Sciences

Gut microbiome alterations in Alzheimer's disease

Nicholas M. Vogt et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Microglia development follows a stepwise program to regulate brain homeostasis

Orit Matcovitch-Natan et al.

SCIENCE (2016)

Review Biotechnology & Applied Microbiology

Nanomedicine for the treatment of Alzheimer's disease

Maria Gregori et al.

NANOMEDICINE (2015)

Article Neurosciences

Host microbiota constantly control maturation and function of microglia in the CNS

Daniel Erny et al.

NATURE NEUROSCIENCE (2015)

Editorial Material Neurosciences

Anti-inflammatory Signaling in Microglia Exacerbates Alzheimer's Disease-Related Pathology

Jean-Philippe Michaud et al.

NEURON (2015)

Review Clinical Neurology

Targeting the β secretase BACE1 for Alzheimer's disease therapy

Riqiang Yan et al.

LANCET NEUROLOGY (2014)

Review Neurosciences

Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review

Omar Sery et al.

FOLIA NEUROPATHOLOGICA (2013)

Article Gastroenterology & Hepatology

Butyricicoccus pullicaecorum in inflammatory bowel disease

Venessa Eeckhaut et al.

Review Neurosciences

Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation

Wai T. Wong

FRONTIERS IN CELLULAR NEUROSCIENCE (2013)

Article Multidisciplinary Sciences

Gut microbiota composition correlates with diet and health in the elderly

Marcus J. Claesson et al.

NATURE (2012)

Review Clinical Neurology

Microglia in neurodegenerative disease

V. Hugh Perry et al.

NATURE REVIEWS NEUROLOGY (2010)

Article Multidisciplinary Sciences

Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments

Mark R. Etherton et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Biochemistry & Molecular Biology

Microglial activation and its implications in the brain diseases

S. Thameem Dheen et al.

CURRENT MEDICINAL CHEMISTRY (2007)

Article Biochemical Research Methods

Assessing nest building in mice

Robert M. J. Deacon

NATURE PROTOCOLS (2006)

Article Pharmacology & Pharmacy

Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention

B Liu et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)